Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurochem ; 79(1): 221-4, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11595774

ABSTRACT

DeltaFosB is a Fos family transcription factor that is induced by chronic exposure to cocaine and other drugs of abuse in the nucleus accumbens and related striatal regions, brain regions that are important for the behavioral effects of these drugs. To better understand the mechanisms by which DeltaFosB contributes to the effects of chronic drug treatment, we used DNA microarray analysis to identify genes that are regulated in the nucleus accumbens upon DeltaFosB expression in inducible bitransgenic mice. One of the most highly regulated genes was that encoding a subunit of another transcription factor, nuclear factor-kappaB (NF-kappaB). Subsequent experiments confirmed the induction of NF-kappaB in the nucleus accumbens of mice overexpressing DeltaFosB as well as in wild-type mice treated chronically, but not acutely, with cocaine. These results establish NF-kappaB as a putative target for DeltaFosB and implicate NF-kappaB signaling pathways in the long-term adaptations of nucleus accumbens neurons to cocaine.


Subject(s)
Cocaine/pharmacology , NF-kappa B/biosynthesis , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Proto-Oncogene Proteins c-fos/physiology , Animals , Blotting, Western , Cocaine/administration & dosage , Gene Expression , I-kappa B Proteins/metabolism , Male , Mice , Mice, Transgenic , Oligonucleotide Array Sequence Analysis , Protein Subunits , Proto-Oncogene Proteins c-fos/genetics
2.
Mol Cell Biol ; 17(11): 6265-73, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9343387

ABSTRACT

The Notch genes of Drosophila melanogaster and vertebrates encode transmembrane receptors that help determine cell fate during development. Although ligands for Notch proteins have been identified, the signaling cascade downstream of the receptors remains poorly understood. In human acute lymphoblastic T-cell leukemia, a chromosomal translocation damages the NOTCH1 gene. The damage apparently gives rise to a constitutively activated version of NOTCH protein. Here we show that a truncated version of NOTCH1 protein resembling that found in the leukemic cells can transform rat kidney cells in vitro. The transformation required cooperation with the E1A oncogene of adenovirus. The transforming version of NOTCH protein was located in the nucleus. In contrast, neither wild-type NOTCH protein nor a form of the truncated protein permanently anchored to the plasma membrane produced transformation in vitro. We conclude that constitutive activation of NOTCH similar to that found in human leukemia can contribute to neoplastic transformation. Transformation may require that the NOTCH protein be translocated to the nucleus. These results sustain a current view of how Notch transduces a signal from the surface of the cell to the nucleus.


Subject(s)
Cell Transformation, Neoplastic/genetics , Leukemia, Experimental/genetics , Leukemia-Lymphoma, Adult T-Cell/genetics , Membrane Proteins/genetics , Receptors, Cell Surface/genetics , Transcription Factors , Adenovirus E1A Proteins/genetics , Alleles , Animals , Biological Transport , Cell Compartmentation , Cell Nucleus/metabolism , Humans , Rats , Receptor, Notch1 , Receptor, Notch2 , Sequence Deletion
3.
Cell ; 90(2): 281-91, 1997 Jul 25.
Article in English | MEDLINE | ID: mdl-9244302

ABSTRACT

Previous models for signal transduction via the Notch pathway have depicted the full-length Notch receptor expressed at the cell surface. We present evidence demonstrating that the Notch receptor on the plasma membrane is cleaved. This cleavage is an evolutionarily conserved, general property of Notch and occurs in the trans-Golgi network as the receptor traffics toward the plasma membrane. Although full-length Notch is detectable in the cell, it does not reach the surface. Cleavage results in a C-terminal fragment, N(TM), that appears to be cleaved N-terminal to the transmembrane domain, and an N-terminal fragment, N(EC), that contains most of the extracellular region. We provide evidence that these fragments are tethered together on the plasma membrane by a link that is sensitive to reducing conditions, forming a heterodimeric receptor.


Subject(s)
Cell Membrane/chemistry , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Blotting, Western , Cell Membrane/metabolism , Cells, Cultured , Dimerization , Golgi Apparatus/chemistry , Golgi Apparatus/metabolism , Humans , Intracellular Signaling Peptides and Proteins , Keratinocytes/chemistry , Keratinocytes/cytology , Keratinocytes/metabolism , Membrane Proteins/metabolism , Molecular Sequence Data , Molecular Weight , Protein Structure, Tertiary , Receptor, Notch2 , Receptors, Cell Surface/chemistry , Sequence Homology, Amino Acid
4.
Proc Natl Acad Sci U S A ; 92(14): 6414-8, 1995 Jul 03.
Article in English | MEDLINE | ID: mdl-7604005

ABSTRACT

The development of cancer is a cellular process that reflects and is partly driven by alterations in cell determination. Mutations in various molecules responsible for cell determination have been identified as being oncogenic, but little is known about the involvement of normal cell fate-determining mechanisms in the oncogenic process. The Notch pathway defines an evolutionarily conserved, general cell interaction mechanism that controls fundamental aspects of cell determination during vertebrate and invertebrate development. We have explored the involvement of the human Notch pathway in human cervical tissues, which define a cellular environment where cell fate changes take place and where neoplastic conditions have been well characterized. Our evidence suggests that Notch expression is associated with cell populations that are undergoing cell fate changes and that Notch activity can be used to monitor cell fate abnormalities in cervical as well as other epithelial neoplasias.


Subject(s)
Membrane Proteins/physiology , Signal Transduction , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/physiopathology , Antibodies , Antibody Specificity , Female , Fluorescent Antibody Technique , Gene Expression , Humans , Membrane Proteins/analysis , Membrane Proteins/biosynthesis , Mutation , Receptors, Cell Surface/physiology , Receptors, Notch , Uterine Cervical Neoplasms/genetics
5.
J Virol ; 67(12): 7533-8, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8230472

ABSTRACT

Previous studies have shown that trimers of the vesicular stomatitis virus glycoprotein (VSV G protein) are in rapid equilibrium with monomeric subunits after folding and assembly in the endoplasmic reticulum (ER). To determine whether G protein trimers were in equilibrium with monomers in other cellular compartments, we studied heterotrimer formation between VSV G protein and a mutant G protein (G mu protein) containing a 3-amino-acid cytoplasmic domain replacing the normal 29-amino-acid domain. The G mu protein is transported from the ER much more slowly than G protein, although both G and G mu proteins form trimers rapidly in the ER. In coexpression experiments, we observed that VSV G protein molecules exited the ER about sixfold faster than G mu protein molecules, and we observed no heterotrimer formation in the ER, probably because of rapid reassortment of the mutant and wild-type trimers. However, heterotrimer formation between the two proteins was observed after long chase periods that allowed time for trimers of the mutant protein to reach the plasma membrane and reassort with the G protein subunits. Additional studies showed that heterotrimers of the two proteins could form in the Golgi or in the ER if exit of the G protein from either compartment was blocked.


Subject(s)
Cell Membrane/metabolism , Golgi Apparatus/metabolism , Membrane Glycoproteins , Vesicular stomatitis Indiana virus/metabolism , Viral Envelope Proteins/metabolism , Animals , Antibodies, Viral/immunology , Antibody Specificity , Biological Transport , Brefeldin A , Cell Compartmentation , Cells, Cultured , Cricetinae , Cyclopentanes/pharmacology , Hexosaminidases/pharmacology , Mutation , Postural Balance , Protein Conformation , Protein Processing, Post-Translational , Vesicular stomatitis Indiana virus/drug effects , Viral Envelope Proteins/drug effects , Viral Envelope Proteins/immunology
6.
J Virol ; 65(4): 1976-84, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1848313

ABSTRACT

The vesicular stomatitis virus (VSV) glycoprotein (G) forms noncovalently linked trimers in the endoplasmic reticulum (ER) prior to transport to the cell surface. Here we examined the formation of heterotrimers between wild-type and mutant subunits that were retained in the ER by C-terminal retention signals. When G protein was coexpressed with mutant subunits that formed trimers at the wild-type rate and were transported from the ER at the wild-type rate, heterotrimers were readily detected. In contrast, when G protein was coexpressed with mutant subunits that formed trimers at the wild-type rate, but were retained in the ER, heterotrimers were not detected unless transport of the wild-type molecules from the ER was blocked. After removal of transport block, the heterotrimers then dissociated and reassorted to homotrimers of the mutant protein that were retained in the ER and wild-type trimers that were transported to the cell surface. These and other results presented here indicate that there is an equilibrium between G protein trimers and monomers in vivo, at least in the ER. This equilibrium may function to allow escape of wild-type subunits from aberrant retained subunits.


Subject(s)
Endoplasmic Reticulum/metabolism , Membrane Glycoproteins/metabolism , Vesicular stomatitis Indiana virus/metabolism , Viral Envelope Proteins/metabolism , Animals , Antiviral Agents/pharmacology , Base Sequence , Biological Transport , Brefeldin A , Cells, Cultured , Chemical Precipitation , Cricetinae , Cyclopentanes/pharmacology , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/microbiology , Kinetics , Membrane Glycoproteins/genetics , Molecular Sequence Data , Mutagenesis , Vesicular stomatitis Indiana virus/drug effects
7.
J Virol ; 64(10): 4907-13, 1990 Oct.
Article in English | MEDLINE | ID: mdl-2168975

ABSTRACT

We have recently described an assay in which a temperature-sensitive mutant of vesicular stomatitis virus (VSV; mutant tsO45), encoding a glycoprotein that is not transported to the cell surface, can be rescued by expression of wild-type VSV glycoproteins from cDNA (M. Whitt, L. Chong, and J. Rose, J. Virol. 63:3569-3578, 1989). Here we examined the ability of mutant G proteins to rescue tsO45. We found that one mutant protein (QN-1) having an additional N-linked oligosaccharide at amino acid 117 in the extracellular domain was incorporated into VSV virions but that the virions containing this glycoprotein were not infectious. Further analysis showed that virus particles containing the mutant protein would bind to cells and were endocytosed with kinetics identical to those of virions rescued with wild-type G protein. We also found that QN-1 lacked the normal membrane fusion activity characteristic of wild-type G protein. The absence of fusion activity appears to explain lack of particle infectivity. The proximity of the new glycosylation site to a sequence of 19 uncharged amino acids (residues 118 to 136) that is conserved in the glycoproteins of the two VSV serotypes suggests that this region may be involved in membrane fusion. The mutant glycoprotein also interferes strongly with rescue of virus by wild-type G protein. The strong interference may result from formation of heterotrimers that lack fusion activity.


Subject(s)
Membrane Fusion , Membrane Glycoproteins , Mutation , Vesicular stomatitis Indiana virus/genetics , Viral Envelope Proteins/genetics , Animals , Cell Line , Cell Transformation, Viral , Endocytosis , Glycosylation , Kinetics , L Cells/metabolism , Mice , Vesicular stomatitis Indiana virus/physiology , Viral Envelope Proteins/metabolism , Virion/genetics , Virion/metabolism
8.
J Cell Biol ; 109(6 Pt 1): 2633-40, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2592401

ABSTRACT

The sequence Ser-Glu-Lys-Asp-Glu-Leu (SEKDEL) has been shown to be a signal which leads to retention of at least two proteins in the endoplasmic reticulum of animal cells (Munro and Pelham, 1987). In this study we tested the function of this signal by appending it to two secretory proteins, rat growth hormone and the alpha subunit of human chorionic gonadotrophin (hCG-alpha). We used oligonucleotide-directed mutagenesis and expression to generate proteins with SEKDEL added to the exact COOH termini and then carried out a detailed analysis of their transport in monkey COS cells. We found that transport was not blocked for either protein, but rather that the half-time for secretion was increased about sixfold for both proteins. Analysis of oligosaccharide processing on hCG-alpha-SEKDEL and indirect immunofluorescence microscopy on cells expressing both proteins was consistent with a retardation of transport between the endoplasmic reticulum and the Golgi apparatus. A change in the last amino acid of the SEKDEL sequence from Leu to Val abolished the retardation almost completely, suggesting a highly specific interaction of the sequence with a receptor. A change in the first amino acid had little or no effect on retardation. We conclude that the SEKDEL signal can have strong effects on reducing the rate of protein exit from the endoplasmic reticulum without generating absolute retention. Presumably other features of protein structure must be important to generate absolute retention.


Subject(s)
Chorionic Gonadotropin/metabolism , Endoplasmic Reticulum/metabolism , Growth Hormone/metabolism , Protein Sorting Signals/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Golgi Apparatus/metabolism , Growth Hormone/genetics , HeLa Cells/metabolism , Humans , Kinetics , Molecular Sequence Data , Mutation , Oligonucleotide Probes , Plasmids , Rats
9.
J Virol ; 63(12): 5328-33, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2555557

ABSTRACT

The vesicular stomatitis virus glycoprotein forms noncovalently linked trimers in the endoplasmic reticulum before being transported to the Golgi apparatus. The experiments reported here were designed to determine if the extracellular domain of the glycoprotein contains structural information sufficient to direct trimer formation. To accomplish this, we generated a construct encoding G protein with the normal transmembrane and anchor sequences replaced with the sequence encoding 53 C-terminal amino acids from the Thy-1.1 glycoprotein. We show here that these sequences were able to specify glycolipid addition to the truncated G protein, probably after cleavage of 31 amino acids derived from Thy-1.1. The glycolipid-anchored G protein formed trimers and was expressed on the cell surface in a form that could be cleaved by phosphoinositol-specific phospholipase C. However, the rate of transport was reduced, compared with that of wild-type G protein. A second form of the G protein was generated by deletion of only the transmembrane and cytoplasmic domains. This mutant protein also formed trimers with relatively high efficiency and was secreted slowly from cells.


Subject(s)
Glycolipids/metabolism , Membrane Glycoproteins/genetics , Vesicular stomatitis Indiana virus/genetics , Viral Envelope Proteins/genetics , Acetylglucosaminidase/metabolism , Amino Acid Sequence , Base Sequence , Centrifugation, Density Gradient , Codon/genetics , Electrophoresis, Polyacrylamide Gel , HeLa Cells/metabolism , Humans , Kinetics , Macromolecular Substances , Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase , Molecular Sequence Data , Restriction Mapping , Solubility , Viral Envelope Proteins/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...